The Food and Drug Administration (FDA) announced Thursday it plans to phase out animal testing requirements for biological products and drugs, instead moving toward alternative testing models such ...
However, when it comes to other alternative methods, such as computer-based models and cell-based tests, substantial further development is still required." Better for both animals and humans ...
The FDA is moving away from requiring animal models for investigational new drug (IND) applications for new monoclonal antibodies and some other drug candidates. Animal testing will be "reduced, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback